Abstract
We describe herein the case of a 57-year-old man with thalassemia who developed acute liver failure after undergoing endoscopic injection sclerotherapy (EIS) to control hemorrhage from a ruptured esophageal varix. The patient, who had been comfirmed as having liver cirrhosis due to chronic hepatitis C with thalassemia in 1989, was admitted to our department to undergo EIS for esophageal varices, at which time his serum total bilirubin level was 5.5 mg/dl. As a small amount of hematemesis occurred just after a percutaneous transhepatic portography was performed, emergency EIS was carried out, following which the serum total bilirubin level markedly increased, mainly with a direct fraction, until it reached 70 mg/dl. The patient eventually died from acute liver failure with extreme hyperbilrubinemia on the 27th day after experiencing hematemesis despite all treatment. This unfortunate case demonstrates that sclerotherapy could be an inappropriate method of treatment for patients with hemolytic disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hashizume M, Kitano S, Koyanagi N, Tanoue K, Ohta M, Wada H, Yamaga H, Higashi H, Iso Y, Iwanaga T, Sugimachi K (1992) Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study. Hepatology 15:69–75
Hashizume M, Kitano S, Yamaga H, Sugimachi K (1988) Haptoglobin to protect against renal demage from ethanolamine oleate sclerosant. Lancet 2:340–341
Stiegmann GV (1989) Endoscopictreatment of esophageal varices. In: Rutherford RB (ed) Vascular surgery, 3rd edn. Saunders, Philadelphia, pp 1145–1155
Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M (1981) Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213–218
Weatherall DJ, Clegg JB (1981) The thalassemia syndromes, 3rd edn. Blackwell Scientific Publications, Oxford
Bynum TE, Boitnott JK, Maddrey WC (1979) Ischemic hepatitis. Dig Dis Sci 24:129–135
Schubert TT (1986) Hepatobiliary system in sickle cell disease. Gastroenterology 90:2013–2021
Stiegmann GV, Goff JS, Michaletz-Onody PA, Kolura J, Lieberman D, Saeed ZA, Reveille RM, Sun JH, Lowenstein SR (1992) Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326:1527–1532
Hashizume M, Ohta M, Ueno K, Tanoue K, Kitano S, Sugimachi K (1993) Endoscopic ligation of esophageal varices compaired with injection sclerotherapy: a prospective randomized trial. Gastrointest Endosc 39:123–126
Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL (1992) Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med 116:304–309
Krishnamurthy M, Elguezabal A, Lee CK, Dosik H (1978) Case report bland cholestasis: Unusual hepatic sequela in sickle cell anemia. Postgrad Med 64:215–217
Mallouh AA, Mohammed I (1986) Acute cholestatic jaundice in children with sickle cell disease: Hepatic crises or hepatitis? Pediatr Infect Dis J 7:689–692
Sheehy TW (1977) Sickle cell hepatopathy. South Med J 70:533–538
Owen DM, Aldridge JE, Thompson RB (1965) An unusual hepatic sequela of sickle cell anemia: A report of five cases. Am J Med Sci 249:175–185
Wade FA (1960) Sickle cell crisis resembling obstructive (cholangiolar type) jaundice: Report of a case and review of the literature. Va Med Month 87:747–748
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nishioka, K., Hashizume, M., Kitano, S. et al. Extreme hyperbilirubinemia induced by endoscopic injection sclerotherapy in a patient with esophageal varices and thalassemia: Report of a case. Surg Today 26, 53–56 (1996). https://doi.org/10.1007/BF00311993
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00311993